Next Article in Journal
Marine Natural Products with P-Glycoprotein Inhibitor Properties
Next Article in Special Issue
Gageostatins A–C, Antimicrobial Linear Lipopeptides from a Marine Bacillus subtilis
Previous Article in Journal
Hyaluromycin, a New Hyaluronidase Inhibitor of Polyketide Origin from Marine Streptomyces sp.
Previous Article in Special Issue
Thiopeptide Antibiotics: Retrospective and Recent Advances
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Analysis of the Toxicity and Histopathology Induced by the Oral Administration of Pseudanabaena galeata and Geitlerinema splendidum (Cyanobacteria) Extracts to Mice

1
Immunopathology Laboratory, Butantan Institute, Av. Vital Brasil, 1500, Sao Paulo SP 05503-900, Brazil
2
Phycology Section, Institute of Botany, Av. Miguel Stéfano, 3687, Sao Paulo SP 04301-902, Brazil
3
Department of Genetics, Butantan Institute, Av. Vital Brasil, 1500, Sao Paulo SP 05503-900, Brazil
*
Author to whom correspondence should be addressed.
Mar. Drugs 2014, 12(1), 508-524; https://doi.org/10.3390/md12010508
Submission received: 1 November 2013 / Revised: 30 December 2013 / Accepted: 30 December 2013 / Published: 22 January 2014

Abstract

:
Cyanobacteria are common members of the freshwater microbiota in lakes and drinking water reservoirs, and are responsible for several cases of human intoxications in Brazil. Pseudanabaena galeata and Geitlerinema splendidum are examples of the toxic species that are very frequently found in reservoirs in Sao Paulo, which is the most densely populated area in Brazil. In the search for toxic strains collected from water reservoirs and maintained in the Cyanobacterial Culture Collection (CCIBt) of the Institute of Botany of Brazil, the acetic acid extracts (AE) of P. galeata CCIBt 3082 and G. splendidum CCIBt 3223 were analyzed by planar chromatography, which indicated the absence of cyanotoxins. Animal tests were then carried out, and both extracts were found to induce toxic effects in mice when administered intraperitoneally. The present study aimed to investigate whether the oral ingestion of the above mentioned cyanobacteria extracts would also induce toxic effects in mice. Necropsy and histopathological studies were conducted using tissue samples from the animals, which were euthanized one week after the administration of the extracts. The AE of P. galeata did not cause death but did induce transient symptoms, including eyebrow ptosis, straub tail, and pain. The euthanized animals presented hemorrhage in the liver, whereas the histological analysis showed disorganization of the hepatic parenchyma, necrosis, hyperemia, and proximity of the centrilobular vein in the liver. In addition, alterations in the convoluted tubules of the kidneys were observed, and the lungs were unaffected. The AE of G. splendidum caused only one death, and induced transient symptoms, such as dyspnea, paralysis, and pain, in the other mice. The necropsy of the euthanized mice showed hemorrhage in the lungs and liver. The lungs presented hemorrhagic focuses, alveolar collapse, and granulomatous foci. The liver presented hemorrhagic and enlarged sinusoids, hyperemia, proximity of the centrilobular vein, and disorganization of the hepatic parenchyma. Some areas also exhibited an inflammatory infiltrate and calcified tissue inside blood vessels. Necrosis and rupture of the convoluted tubule cells were observed in the kidneys. Further analysis of the both extracts indicated the lack of hemolytic activity, and the presence of two unknown anti-AChE substances in the AE of G. splendidum. Thus, P. galeata and G. splendidum are producers of novel toxins that affect mammals when administered orally.

1. Introduction

Many bioactive natural products have been characterized from cyanobacteria in the past few years [1,2,3,4,5,6,7]. Some compounds are of medical and/or pharmaceutical importance as they exhibit antimicrobial, antifungal, and anticancer activities [8,9]. However, some of these metabolites are toxic toward a great variety of organisms, including humans [10,11].
According to the review compiled by Skulberg et al. [12], of the two thousand cyanobacteria species comprising 150 genera, 40 species are toxic. There is much to be investigated in this field of research as only 5%–10% of the cyanobacterial biodiversity from the tropical regions was evaluated in terms of their taxonomy and toxicity until the last decade [13]. Cyanobacteria toxins, which are also called cyanotoxins, can affect the gastric, hepatic, and neural systems, and can induce mutagenic and teratogenic effects, toxic effects on gonads and embryos, and tumor promotion [14]. Cyanotoxins are classified as hepatotoxins, neurotoxins, cytotoxins, dermatotoxins, and/or irritant toxins according to their effects on mammals [15,16,17].
A cyanobacterial bloom formation may occur in a water body under specific conditions. The release of cyanotoxins, such as microcystins, saxitoxins, anatoxin-a, anatoxin-a(S), and cylindrospermopsins, in water reservoirs that are used for human consumption can cause public health problems [16,18,19,20,21]. These substances can be the source of acute lethal intoxications or may induce the development of chronic diseases, e.g., the continuous ingestion of sub-lethal doses of microcystins promotes the growth of hepatic tumors or necrosis [22,23].
The current legislation in Brazil on cyanobacteria toxins in water reservoirs for human and animal consumption is mandatory only for microcystins and saxitoxins, whereas the analysis of the water for the presence of cylindrospermopsin and anatoxin-a(S) is only performed if cyanobacteria that potentially produce these compounds are observed [24].
In our studies of Brazilian cyanobacteria, we demonstrated that some species that do not typically form blooms but are frequently found in our water reservoirs and urban lakes produce toxins other than the known cyanotoxins. As a standard procedure of the screening program for toxic strains collected from water reservoirs and maintained in the Cyanobacterial Culture Collection (CCIBt) of the Institute of Botany of Brazil, the extracts of all cyanobacteria are analyzed by HPTLC (high performance thin layer chromatography) to detect cyanotoxins (microcystins, saxitoxins, anatoxin-a, and β-methylamino-l-alanine). Only the extracts with negative results (no cyanotoxin) are tested in mice bioassay. According to Harada et al. [25], mouse bioassay is the standard test for toxicity evaluation of biomass produced by blooms or cultures of dinoflagellates and cyanobacteria. This test is also important to characterize cyanobacteria toxins, as the symptoms presented by intoxicated animal, the time to death after injection, and post-mortem examination may indicate the toxin’s nature. Furthermore, bioassays are necessary when there is indication of the presence of cyanotoxins other than (or in addition to) the known toxicants [25]. Although cell-based assays (or ELISA kits or other analytical methods) for standard cyanotoxins detection are relevant to monitoring programs, they will not provide enough evidence that animals or people can be intoxicated or poisoned by ingesting the cyanobacteria or their cell’s contents present or released in the water reservoirs when the presence of unknown toxins is suspected.
Two species from the Geitlerinema genus exhibited toxicity to mice (i.p.—intraperitoneal administration) due to the presence of pro-inflammatory and antiacetylcholinesterase (anti-AChE) substances in their extracts: the methanol extract (ME) of Geitlerinema unigranulatum CCIBt 3213 [17,26,27] and the acetic acid extract (AE) of Geitlerinema splendidum CCIBt 3223 [17,28]. Geitlerinema spp. does not usually form blooms, but the CCIBt 3223 strain was found in the Guarapiranga reservoir in Sao Paulo City, which is a eutrophic drinking water reservoir in the highest populated area of Brazil [17].
Another species that has been studied by our group is Pseudanabaena galeata. The strain P. galeata CCIBt 3082 was also collected in an urban lake in Sao Paulo. Its AE caused hepatic damage when administered intraperitoneally to mice, and body weight reduction and tumor promotion was observed in the liver one week after the administration of a single dose [29].
In the present study, we performed bioassays to determine the toxicity induced by the oral administration of the AEs of P. galeata CCIBt 3082 and G. splendidum CCIBt 3223 to mice. This study aimed to demonstrate that the ingestion of the aqueous content of these cyanobacteria can induce toxicity symptoms or death in mammal and affect the histological aspects of vital organs. We also investigated whether the toxins exert an unspecific effect in cell membranes through a hemolytic assay with mouse erythrocytes.

2. Results

The mice administered with Milli-Q exhibited no intoxication symptoms, presented no post-mortem alterations in the necropsy of the euthanized animals, and showed no microscopic alterations in the organs (lungs, kidneys, and liver), as shown in Figure 1.
Figure 1. Histological sections of the organs of control mice stained with hematoxylin and eosin. (A,B) lung; (C,D) liver; (E,F) kidney.
Figure 1. Histological sections of the organs of control mice stained with hematoxylin and eosin. (A,B) lung; (C,D) liver; (E,F) kidney.
Marinedrugs 12 00508 g001
At a dosage of 1 g kg−1, the AE P. galeata CCIBt3082 did not cause death but induced various symptoms, including eyebrow ptosis, straub tail, and pain. One week after administration, the euthanized animals presented hemorrhage in the liver. The histology showed disorganization of the hepatic parenchyma, necrosis, hyperemia, and proximity of the centrilobular vein (Figure 2A–C). In addition, the kidneys presented enlargement and cellular hypertrophy of convoluted tubules (Figure 2D), and the lungs were unaffected.
Figure 2. Histological sections of mice organs after the oral administration of the AE of P. galeata (1 g kg−1 b.w.). The liver is shown in A, B, and C, and the kidney is shown in D. (A) Hyperemia and proximity of the centrilobular vein (circles) and disorganization of the hepatic parenchyma. (B) Proximity of the centrilobular vein (circle) and disorganization of the hepatic parenchyma (circle). (C) Necrosis (circle), vacuolization of liver cells (arrows), and disorganization of the hepatic parenchyma. (D) Alterations in the convoluted tubules, characterized by cellular hypertrophy (circle) and expansion of the tubules (arrows).
Figure 2. Histological sections of mice organs after the oral administration of the AE of P. galeata (1 g kg−1 b.w.). The liver is shown in A, B, and C, and the kidney is shown in D. (A) Hyperemia and proximity of the centrilobular vein (circles) and disorganization of the hepatic parenchyma. (B) Proximity of the centrilobular vein (circle) and disorganization of the hepatic parenchyma (circle). (C) Necrosis (circle), vacuolization of liver cells (arrows), and disorganization of the hepatic parenchyma. (D) Alterations in the convoluted tubules, characterized by cellular hypertrophy (circle) and expansion of the tubules (arrows).
Marinedrugs 12 00508 g002
At dosages of 0.5, 1, and 2 g kg−1, the AE G. splendidum CCIBt 3223 induced dyspnea, paralysis, and pain (and one death at a dosage of 0.5 g, kg−1), which indicates that this strain presents low toxicity according to the scale described by Lawton et al. [30]. The necropsy of the euthanized mice showed hemorrhage in the lungs and liver. The lungs presented hemorrhagic focuses, alveolar collapse, and granulomatous foci (macrophages) (Figure 3). The liver presented hemorrhagic and enlarged sinusoids, hyperemia, proximity of the centrilobular vein, and disorganization of the hepatic parenchyma (Figure 4A–D). Some areas presented inflammatory infiltrate (Figure 4D) and calcified tissue inside the blood vessels (Figure 4E–F). Necrosis and rupture of convoluted tubule cells were observed in the kidneys (Figure 5).
Figure 3. Histological sections of mice lungs after the oral administration of the AE of G. splendidum. The sections were stained with hematoxylin and eosin, (A,B) 0.5 g kg−1 body weight (b.w.); hemorrhagic focuses (circle), artery distention (square), and alveolar collapse. (C,D) 1 g kg−1 b.w.; hemorrhagic focuses (circle). (E,F) 2 g kg−1 b.w.; hemorrhagic focuses (square) and granulomatous foci (circle).
Figure 3. Histological sections of mice lungs after the oral administration of the AE of G. splendidum. The sections were stained with hematoxylin and eosin, (A,B) 0.5 g kg−1 body weight (b.w.); hemorrhagic focuses (circle), artery distention (square), and alveolar collapse. (C,D) 1 g kg−1 b.w.; hemorrhagic focuses (circle). (E,F) 2 g kg−1 b.w.; hemorrhagic focuses (square) and granulomatous foci (circle).
Marinedrugs 12 00508 g003
Figure 4. Histological sections of mice liver after the oral administration of the AE of G. splendidum. The sections were stained with hematoxylin and eosin. (A,B) 0.5 g kg−1 b.w.; hemorrhagic and enlarged sinusoids (arrows) and hyperemia of centrilobular vein (circle). (C) 1 g kg−1 b.w.; hyperemia and proximity of the centrilobular vein (circle). (D) 1 g kg−1 b.w.; inflammatory infiltrate (circle) and disorganization of the hepatic parenchyma. (E,F) 2 g kg−1 b.w.; same observations shown in A-D and calcified tissue inside blood vessels (circles and arrows).
Figure 4. Histological sections of mice liver after the oral administration of the AE of G. splendidum. The sections were stained with hematoxylin and eosin. (A,B) 0.5 g kg−1 b.w.; hemorrhagic and enlarged sinusoids (arrows) and hyperemia of centrilobular vein (circle). (C) 1 g kg−1 b.w.; hyperemia and proximity of the centrilobular vein (circle). (D) 1 g kg−1 b.w.; inflammatory infiltrate (circle) and disorganization of the hepatic parenchyma. (E,F) 2 g kg−1 b.w.; same observations shown in A-D and calcified tissue inside blood vessels (circles and arrows).
Marinedrugs 12 00508 g004
Figure 5. Histological sections of mice kidneys after the oral administration of the AE of G. splendidum. The sections were stained with hematoxylin and eosin. (A,B) 0.5 g kg−1 b.w.; necrotic area in the convoluted tubules (square). (C,D) 1 g kg−1 b.w.; necrosis (circle) and rupture of the convoluted tubules (square).
Figure 5. Histological sections of mice kidneys after the oral administration of the AE of G. splendidum. The sections were stained with hematoxylin and eosin. (A,B) 0.5 g kg−1 b.w.; necrotic area in the convoluted tubules (square). (C,D) 1 g kg−1 b.w.; necrosis (circle) and rupture of the convoluted tubules (square).
Marinedrugs 12 00508 g005
Even at high concentrations of 1 mg/mL of a 4% suspension of mouse erythrocytes (ES), the AEs of P. galeata CCIBt 3082 and G. splendidum CCIBt 3223 exhibited no hemolytic activity against murine red blood cells.

3. Discussion

Previous studies performed as a standard procedure of our screening program at Cyanobacterial Culture Collection of the Institute of Botany of Brazil involved HPTLC experiments to detect the presence of microcystins, saxitoxins, anatoxin-a, and BMAA (accordingly to methods described by [31,32,33,34]). The AEs of P. galeata CCIBt 3082 and G. splendidum CCIBt 3223 presented negative results [28,35]. As both strains are very frequent in our water reservoirs in Sao Paulo area, those where considered as of possible toxicological importance and mice toxicity experiments were conducted to detected the presence of other toxins.
Acute and chronic mice intoxication symptoms and histopathological effects of the most common cyanotoxins have already been described thoroughly in the literature. The signs that indicate the presence of alkaloid neurotoxic cyanotoxins, such as saxitoxins and anatoxins, are: muscle progressive paralysis, overrated abdominal breath, cyanosis, convulsions, respiratory arrest, and death in a few minutes after sample administration, and absence of organ alterations in the post-mortem exam [25]. Differently, the protein phosphatases inhibitors microcystins and nodularins, cyanobacteria hepatotoxic peptides, induce diarrhea, vomit, piloerection, weakness, and paleness in the intoxicated animals. Death occurs from 50 min to 2 h after administration, and the autopsy shows augmented and hemorrhagic liver. Lethal doses of microcystins also induce pulmonary inflammation, congestion, and hemorrhage [36]. Sublethal chronic administration of microcystins causes hepatocytomegaly and karyomegaly with moderate parenchymal disarray in mice liver after four to seven daily doses. Multinucleated hepatocytes containing as many as seven nuclei per cell were commonly seen, mostly adjacent to the central vein, and cytoplasmic vacuolation and apoptosis were also present [37]. Cylindrospermopsin is a toxin that inhibits the protein synthesis in the cells (in vitro and in vivo). When administrated in mice reduces the levels of mobility and responsiveness, causes mild piloerection and diarrhea. The deaths occur at least after 6 h after i.p. administration up to six to seven days depending on the dose [38,39,40]. Oral or intraperitoneal administration of cylindrospermopsin in mice induces, after 24 h, primary DNA damage in the colon as well as cell death in the liver and kidneys [41]. The lipopolysacharides (LPS), cell wall components of gram-negative bacteria, are pyrogenic (fever causing agents) and toxic. The few studies carried out on cyanobacterial LPS indicate that they are less toxic than the LPS of other bacteria, such as Salmonella. Furthermore, acute LD50 values in mice are at least tenfold higher than the doses used at the present work, in addition, the method for extraction of cyanobacterial LPS is different than ours ([39,42] and cited references).
The AEs of P. galeata CCIBt 3082 and G. splendidum CCIBt 3223 are toxic to mice when injected intraperitoneally and induce microscopic lesions in vital organs, as previously described [17,29]. We conducted this study to determine whether the observed toxic effects after intraperitoneal administration also occur when the same extracts are administered orally.
The literature on the toxic effects of P. galeata is scarce. Teneva et al. [43] verified the presence of hepatic and kidney lesions in mice after the intraperitoneal administration of the extract. No mice died after the extract administration, and the liver histology showed granulovacuolar degeneration and mitosis, inflammatory cellular infiltration, obscured cell borders, congestion, hemorrhage, and necrosis, five days after the administration of the extract. The histological alterations in the renal tissue of the treated mice included hemorrhage, inflammation between tubules, necrosis and destruction of tubular cells, and atrophy of the glomerulus. Microcystins, saxitoxins, and anatoxin-A were detected in the P. galeata extract by HPLC and ELISA [43]. Microcystin is a hepatotoxin, whereas the other two toxins are considered neurotoxins with a rapid effect. In our experiments, we also verified the presence of liver and kidney lesions in mice after the oral administration of the AE of P. galeata CCIBt 3082 (Figure 2). However, the intoxication symptoms presented (eyebrow ptosis, straub tail, and pain) and several of the developed lesions observed through histological analysis (hyperemia, proximity of the centrilobular vein, necrosis in the liver, and enlargement and cellular hypertrophy of convoluted tubules in the kidney) were different from those described by Teneva et al. [43] and different from the signals typically described for microcystin intoxication [25,36,37], as explained above. The pain symptoms observed in the mice in our experiment may have been caused by the necrosis observed in the liver because pain due to widespread necrosis in a range of tissues would likely have resulted in hind region effects [44].
The oral administration of the AE of G. splendidum CCIBt 3223 generally induced the same symptoms and lesions in mice that were induced by its intraperitoneal administration [17]. The observed intoxication symptoms did not resemble the effects provoked by hepatotoxins, such as microcystins, but hepatic hemorrhage was visible at the post-mortem exam. Neurotoxins (such as saxitoxin and anatoxin), LPS, and cylindrospermopsins would also cause different symptoms, or were absent in the extract due to the extraction methods employed in this work. Furthermore, the chemical analysis of this extract indicated the absence of both microcystin and saxitoxin [28,35].
The subsequent histological analysis of the liver, lungs, and kidneys corroborated the hypothesis that a different toxin is present in these extracts because the analysis of the tissues and cells, particularly the lungs, indicated the presence of a pro-inflammatory substance. The augmented number of cells in the lung tissue must be related to the recruitment of inflammatory cells, such as macrophages. The extracts of another Geitlerinema species also exhibited pro-inflammatory activity [26]. Another interesting observation was the evidence of healing processes in the liver, as suggested by the proximity of the centrilobular veins and disorganization of the hepatic parenchyma. This finding was most likely observed because the animals were euthanized eight days after the administration of the extract; thus, it is possible that the organs lesions started to heal. Similar cellular damage and tissue repair in the mice liver was observed after the intraperitoneal administration of a Limnothrix sp. extract. The infiltration of leukocytes, macrophages, and neutrophils was observed in the liver, kidneys, and lungs. Furthermore, this Limnothrix sp. strain exhibited morphological characteristics that were very similar to those of Geitlerinema unigranulatum [44].
More recently, two substances with antiacetylcholinesterase (anti-AChE) activity were detected by TLC autography in the AE of G. splendidum CCIBt 3223 [28]. When injected into mice (i.p.), the extract containing these anti-AChE substances indicated a lethal anti-AChE activity, most likely by the presence of long acting (irreversible and, thus, toxic) inhibitory substances to the enzyme. When administrated per os the absorption of toxic components can be reduced, therefore in the results presented here only one death occurred (at the dosage of 0.5 g kg−1) and the symptoms where mild when compared to i.p. administration. Two symptoms observed in the mice following the oral administration of the AE of G. splendidum CCIBt 3223 could be associated with the systemic effects induced by an anti-AChE drug: dyspnea, which is related to the muscarinic receptors, while paralysis is related to the overstimulation of the nicotinic ACh receptors [28].
Anti-AChE substances have also been identified in a Brazilian strain of G. unigranulatum CCIBt 3213 [27] and were found to cause intoxication symptoms and death when administered intraperitoneally to mice.
In addition, neither the AE of P. galeata CCIBt 3082 nor the AE of G. splendidum CCIBt 3223 induced hemolysis in murine erythrocytes at concentrations up to 1 mg/ml 4% ES. This experiment was performed because the unspecific effects on the cell membrane caused by hemolytic substances may be responsible for mouse death, neurotoxic symptoms, respiratory arrest, pain, and tissue damage [45]. Some previous studies indicate that substances that are haemolytic or cytotoxic due to pore formation in membranes can also present neurotoxic properties [45,46,47,48,49,50,51,52,53,54]. Pore insertion may occur into the cell membranes of various target organs. Hemolysis can, thus, be explained on the basis of an osmotic misbalance of the red cells as consequence of pore induction. Neurotoxic effects, on the other hand, result most probably from widespread nerve membrane depolarization caused by the shunting action of the induced pores. These toxins generally form ion channels that allow the inward flow of Ca2+ and other ions to the pre-synaptic terminals, increasing neurotransmitter release at the neuromuscular junction, and the quanta content of the evoked endplate potentials, producing a progressive membrane depolarization [45]. Membrane depolarization of excitable cells will prevent further action potential conduction and post-synaptic excitability, causing paralysis, and ultimately death by respiratory failure.

4. Experimental Section

4.1. Biomass Production

The strains are maintained in liquid media (ASM-1 and BG-11) under controlled conditions: temperature, 23 ± 1 °C; irradiance, 40–50 µmol m−2 s−1; and photoperiod, 14-h light/10-h dark [55]. The biomass was produced by cultivating the unialgal nonaxenic strain in 9 L of ASM-1 under the same illumination and temperature conditions described above with constant stirring (70 rpm) or aeration until the exponential growth phase was reached. The cells were harvested by centrifugation and frozen at −20 °C.

4.2. Preparation of Cyanobacteria Extracts

For each strain, the freeze-dried cells were extracted with 0.1 M (4×) aqueous acetic acid or a 75:25 (v/v) methanol/water solution by sonication (4×, 10 s, and 50 W). The combined extracts were centrifuged (1830 × g, 50 min), and the supernatants were freeze dried and stored at −18 °C [56].

4.3. Mouse Bioassay

The use of mice in our experiments was in agreement with the Ethical Principles in Animal Research that were adopted by the Brazilian College of Animal Experimentation and was approved by the Ethical Committee for Animal Research of Butantan Institute (Protocol No. 385/07). The toxicity tests were performed in triplicate, and Swiss-Webster male mice (weighing 19–21 g) were used according to the method recommended by the World Health Organization [25], which consists of the administration of a cyanobacteria lysate. The mice were observed for 24 h and then sacrificed using an approved method [10].
Each mouse was orally administered a single dose of 0.5, 1, or 2 g of dried cells per kg of b.w. (body weight) in 0.2 mL of Milli-Q water, which enabled the extracts to be ranked as low-toxicity extracts if an animal death was caused [30]. The symptoms of intoxication and time to death were observed up to the 8th day after the administration of the extract. According to Harada et al. [25], the observation period must be extended to seven days when cylindrospermopsin is suspected. Although we did not particularly suspect of the presence of cylindrospermopsin, we extended the observation period, as was previously performed in the intraperitoneal toxicity assay of P. galeata [29] and Geitlerinema spp. [17] extracts. In both studies, the results indicated that the tissue injury assessment one week after administration is very relevant to this type of investigation. Prolonged observation periods have also been used by other researchers in studies of new groups of cyanobacteria and potentially novel toxins [43,44]. The control animals received 0.2 mL of Milli-Q through gavage. The mice that survived until the end of the observation period were euthanized with CO2. Post-mortem exams were performed in all of the animals to macroscopically observe the appearance of the vital organs (liver, heart, lungs, kidneys, and intestine) and to collect tissue samples for histology (liver, lungs, and kidneys).

4.4. Histological Analysis

The liver, lung, and kidney samples collected from the mouse bioassays were fixed in 10% buffered formalin, processed through conventional histological techniques, and stained with hematoxylin and eosin. Microscopy was performed using an optical microscope (Olympus BX51) equipped with a camera (Olympus Q-Color-5), and the images were recorded in a computer using the Image Pro-Express software.

4.5. Hemolytic Assay

To investigate the possible role of hemolysins, phospholipases, and other toxins that may affect the cell membranes as a cause of the murine toxicity, intoxication symptoms, or lesions in the organs, an hemolytic assay was performed. A 4% suspension of mouse erythrocytes (ES) was prepared as previously described [57,58]. Different concentrations of the extracts were incubated with the ES at room temperature (±22 °C) in an ELISA plate (96 wells) for 1 h and centrifuged (1085 × g for 5 min). The hemolytic activity of the supernatant was measured by the absorbance at 540 nm using the absorbance of the Krebs-Henseleit physiological solution (in mM: NaCl, 113; KH2PO4, 1.2; KCl, 4; MgSO4, 1.2; CaCl2, 2.5; NaHCO3, 25; and glucose, 11.1), which was the vehicle used to administer the extracts, as a blank. Total hemolysis was obtained with 1% Triton X-100, and the percentage of hemolysis was calculated relative to this value.

5. Conclusions

Together with the results previously published by our group [17,28,29], the results of the present study clearly indicate that P. galeata CCIBt 3082 and G. splendidum CCIBt 3223 are producers of novel water-soluble toxins that affect mammals when administered orally. Both species studied are often found in freshwater habitats, including drinking water reservoirs in a highly populated area, raising the question if small amounts of non-monitored toxins can be ingested by the local population. Thus, further work is necessary to chemically and pharmacologically characterize these toxins.

Acknowledgments

This work was supported by CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico) of Brazil (307457/2008-7, 474365/2010-7, and 562213/2010-4), a grant from the Sao Paulo Research Foundation (FAPESP, 2008/00173-4), and INCTTox (Instituto Nacional de Ciência e Tecnologia em Toxinas) of Brazil.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Blunt, J.W.; Copp, B.R.; Hu, W.P.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2008, 25, 35–94. [Google Scholar] [CrossRef]
  2. Blunt, J.W.; Copp, B.R.; Hu, W.P.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2009, 26, 170–244. [Google Scholar] [CrossRef]
  3. Blunt, J.W.; Copp, B.R.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2010, 27, 165–237. [Google Scholar] [CrossRef]
  4. Blunt, J.W.; Copp, B.R.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2011, 28, 196–268. [Google Scholar] [CrossRef]
  5. Blunt, J.W.; Copp, B.R.; Keyzers, R.A.; Munro, M.H.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2012, 29, 144–222. [Google Scholar] [CrossRef]
  6. Blunt, J.W.; Copp, B.R.; Keyzers, R.A.; Munro, M.H.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2013, 30, 237–323. [Google Scholar] [CrossRef]
  7. Hu, G.-P.; Yuan, J.; Sun, L.; She, Z.-G.; Wu, J.-H.; Lan, X.-J.; Zhu, X.; Lin, Y.-C.; Chen, S.P. Statistical research on marine natural products based on data obtained between 1985 and 2008. Mar. Drugs 2011, 9, 514–525. [Google Scholar] [CrossRef]
  8. Martins, R.; Pereira, P.; Welker, M.; Fastner, J.; Vasconcelos, V.M. Toxicity of culturable cyanobacteria strains isolated from the Portuguese coast. Toxicon 2005, 46, 454–464. [Google Scholar] [CrossRef]
  9. El-Sheekha, M.M.; Osmana, M.E.H.; Dyabb, M.A.; Amera, M.S. Production and characterization of antimicrobial active substance from the cyanobacterium Nostoc muscoru. Toxicol. Pharmacol. 2006, 21, 42–50. [Google Scholar]
  10. Falconer, I.R. Measurement of Toxins from Blue-Green Algae in Water and Foodstuffs. In Algal Toxins in Seafood and Drinking Water, 1st ed.; Falconer, I.R., Ed.; Academic Press: London, UK, 1993; Volume 1, pp. 165–175. [Google Scholar]
  11. Carmichael, W.W. The toxins of Cyanobacteria. Sci. Am. 1994, 170, 78–86. [Google Scholar] [CrossRef]
  12. Skulberg, O.M.; Carmichael, W.W.; Codd, G.A.; Skulberg, R. Taxonomy of Toxic Cyanophyceae (Cyanobacteria). In Algal Toxins in Seafood and Drinking Water, 1st ed.; Falconer, I.R., Ed.; Academic Press: London, UK, 1993; Volume 1, pp. 145–164. [Google Scholar]
  13. Komárek, J.; Anagnostidis, K. Cyanoprokaryota Part 2. Oscillatoriales. In Süsswasserflora von Mitteleuropa; 19/2; Büdel, B., Krienitz, L., Gärtner, G., Schagerl, M., Eds.; Elsevier Spektrum Akademischer Verlag: München, Germany, 2005; pp. 1–759. [Google Scholar]
  14. Osborne, N.J.T.; Webb, P.M.; Shaw, G.R. The toxins of Lyngbya majuscula and their human and ecological health effects. Environ. Int. 2001, 27, 381–392. [Google Scholar] [CrossRef]
  15. Fusetani, N.; Kem, W. Marine Toxins: An Overview. In Marine Toxins as Research Tools. Progress in Molecular and Subcellular Biology (Marine Molecular Biotechnology), 1st ed.; Fusetani, N., Kem, W., Eds.; Springer: Berlin, Germany, 2009; Volume 1, pp. 1–44. [Google Scholar]
  16. Pearson, L.; Mihali, T.; Moffitt, M.; Kellmann, R.; Neilan, B. On the chemistry, toxicology and genetics of the cyanobacterial toxins, microcystin, nodularin, saxitoxin and cylindrospermopsin. Mar. Drugs 2010, 8, 1650–1680. [Google Scholar] [CrossRef]
  17. Rangel, M.; Brunetti, R.L.; Garcia, A.N.; Cambui, C.C.N.; Conserva, G.A.A.; Neves, A.C.; Sant’Anna, C.L.; Carvalho, L.R. Acute effects of three Geitlerinema spp. (Cyanobacteria) extracts administrated in mice: Symptoms and histopathological aspects. Phytochem. Rev. 2012, 11, 1–11. [Google Scholar] [CrossRef]
  18. Sivonen, K.; Jones, G. Cyanobacterial Toxins. In Toxic Cyanobacteria in Water: A Guide to Their Public Health Consequences, Monitoring and Management, 1st ed.; Chorus, I., Bartram, J., Eds.; E & FN Spon: London, UK, 1999; Volume 1, pp. 43–112. [Google Scholar]
  19. Azevedo, S.M.F.O.; Carmichael, W.W.; Jochimsen, E.M.; Rinehart, K.L.; Lau, S.; Shaw, G.R.; Eaglesham, G.K. Human intoxication by microcystins during renal dialysed treatment in Caruaru-Brazil. Toxicology 2002, 181–182, 441–446. [Google Scholar] [CrossRef]
  20. Carvalho, L.R.; Pipole, F.; Werner, V.R.; Laughinghouse, H.D.; Camargo, A.C.M.; Rangel, M.; Konno, K.; Sant’Anna, C.L. A toxic cyanobacterial mixed bloom in an urban coastal lake, Rio Grande do Sul State, Southern Brazil. Braz. J. Microbiol. 2008, 39, 761–769. [Google Scholar] [CrossRef]
  21. Van Apeldoorn, M.E.; van Egmond, H.P.; Speijers, G.J.A.; Bakker, G.J.I. Review—Toxins of cyanobacteria. Mol. Nutr. Food Res. 2007, 51, 1–60. [Google Scholar]
  22. MacKintosh, C.; Beattie, K.A.; Klumpp, S.; Cohen, P.; Codd, G.A. Cyanobacterial microcystin-LR is a potent and specific inhibitor of protein phosphatases 1 and 2A from both mammals and higher plants. FEBS Lett. 1990, 264, 187–192. [Google Scholar] [CrossRef]
  23. Runnegar, M.; Berndt, N.; Kong, S.M.; Lee, E.Y.C.; Zhang, L.F. In vivo and in vitro binding of microcystin to protein phosphatase 1 and 2A. Biochem. Biophys. Res. Commun. 1995, 216, 162–169. [Google Scholar] [CrossRef]
  24. Carvalho, M.C.; Agujaro, L.F.; Pires, D.A.; Picoli, C. Planktonic Cyanobateria Manual: Legal and Environmental Aspects and Monitoring Guidelines; CETESB: São Paulo, Brazil, 2013; pp. 1–47. [Google Scholar]
  25. Harada, K.; Kondo, F.; Lawton, L. Laboratory Analysis of Cyanotoxins. In Toxic Cyanobacteria in Water: A Guide to Their Public Health Consequences, Monitoring and Management, 1st ed.; Chorus, I., Bartram, J., Eds.; E & FN Spon: New York, NY, USA, 1999; Volume 1, pp. 369–405. [Google Scholar]
  26. Dogo, C.R.; Bruni, F.M.; Elias, F.; Rangel, M.; Pantoja, P.A.; Sant’Anna, C.L.; Lima, C.; Lopes-Ferreira, M.; Carvalho, L.R. Inflammatory effects of the toxic cyanobacterium Geitlerinema amphibium. Toxicon 2011, 58, 464–470. [Google Scholar] [CrossRef]
  27. Dogo, C.R.; Rangel, M.; Cardoso-Lopes, E.M.; Sant’anna, C.L.; Bruni, F.M.; Lopes-Ferreira, M.; Carvalho, L.R. Evaluation of Anticholinesterasic Activity of Strain SPC 920 Geitlerinema Unigranulatum. In Poisoning by Plants, Micotoxins and Related Toxins, 1st ed.; Riet-Correa, F., Pfister, J., Schild, A.L., Wierenga, T., Eds.; CAB International: Wallingford, CT, USA, 2011; pp. 725–730. [Google Scholar]
  28. Carvalho, L.R.; Neves, A.C.; Conserva, G.A.A.; Brunetti, R.L.; Hentschke, G.S.; Malone, C.F.S.; Torres, L.M.B.; Sant’Anna, C.L.; Rangel, M. Biologically active compounds from cyanobacteria extracts: in vivo and in vitro aspects. Braz. J. Pharmacogn. 2013, 23, 471–480. [Google Scholar]
  29. Brunetti, R.L.; Campos-Junior, A.G.; Garcia, A.N.; Dogo, C.R.; Mattos, L.F.A.; Carvalho, L.R.; Rangel, M. Histopathological evaluation of injected mice with extracts of two toxic cyanobacteria strains. In Proceedings of the XI Reunião Cientifica Anual do Instituto Butantan, Sao Paulo, Brazil, 2–4 December 2009; Memórias do Instituto Butantan: Butantã, Brazil, 2009; Volume 66, pp. 267–267. [Google Scholar]
  30. Lawton, L.A.; Beattie, K.A.; Hawser, S.P.; Campbell, D.L.; Codd, G.A. Evaluation of Assay Methods for the Determination of Cyanobacterial Hepatotoxicity. In Detection Methods for Cyanobacterial Toxins; Codd, G.A., Jefferies, T.M., Keevil, C.W., Potter, E., Eds.; The Royal Society of Chemistry: Cambridge, UK, 1994; pp. 111–116. [Google Scholar]
  31. Pelander, A.; Ojanperä, I.; Lahti, K.; Niinivaara, K.; Vuori, E. Visual detection of cyanobacterial hepatotoxins by thin-layer chromatography and application to water analysis. Water Res. 2000, 34, 2643–2652. [Google Scholar] [CrossRef]
  32. Buckley, L.J.; Ikawa, M.; Sasner, J.J. Isolation of Gonyaulax tamarensis toxins from soft shell clams (Mya arenaria) and a thin-layer chromatographic-fluorometric method for their detection. J. Agric. Food Chem. 1976, 24, 107–110. [Google Scholar] [CrossRef]
  33. Ojanpera, I.; Vuori, E.; Himberg, K.; Waris, M.; Niinivaara, K. Facile detection of anatoxin-a in algal material by thin-layer chromatography with Fast Black K Salt. Analyst 1991, 116, 265–267. [Google Scholar] [CrossRef]
  34. Vega, A.; Bell, E.A. α-amino-β-methylaminopropionic acid, a new amino acid from seeds of Cycas circinalis. Phytochemistry 1967, 6, 759–762. [Google Scholar] [CrossRef]
  35. Conserva, G.A.A.; Sant’Anna, C.L.; Cambui, C.C.N.; Brunetti, R.L.; Rangel, M.; Torres, L.M.B.; Young, M.C.M.; Carvalho, L.R. Prospecção de atividades toxicológicas e farmacológicas em cepas de cianobactérias da Coleção de Culturas do Instituto de Botânica (“Screening of toxicological and pharmacological activities in cyanobacteria strains of the Culture Collection of the Institute of Botany”). In Proceedings of the 18ª Reunião Cientifica Anual do Instituto de Botânica, Sao Paulo, Brazil, 21–25 November 2011; pp. 1–4.
  36. Gupta, N.; Pant, S.C.; Vijayaraghavan, R.; Lakshmana Rao, P.V. Comparative toxicity evaluation of cyanobacterial cyclic peptide toxin microcystin variants (LR, RR, YR) in mice. Toxicology 2003, 188, 285–296. [Google Scholar] [CrossRef]
  37. Guzman, R.E.; Solter, P.F. Characterization of sublethal microcystin-LR exposure in mice. Vet. Pathol. 2002, 39, 17–26. [Google Scholar] [CrossRef]
  38. Hawkins, P.R.; Runnegar, M.T.C.; Jackson, A.R.B.; Falconer, I.R. Severe hepatotoxicity caused by the tropical Cyanobacterium (Blue-Green Alga) Cylindrospermopsis raciborskii (Woloszynska) Seenaya and Subba Raju isolated from a domestic water supply reservoir. Appl. Environ. Microbiol. 1985, 50, 1292–1295. [Google Scholar]
  39. Kuiper-Goodman, T.; Falconer, I.; Fitzgerald, J. Human Health Aspects. In Toxic Cyanobacteria in Water: A Guide to Their Public Health Consequences, Monitoring and Management, 1st ed.; Chorus, I., Bartram, J., Eds.; E & FN Spon: New York, NY, USA, 1999; Volume 1, pp. 125–160. [Google Scholar]
  40. Fastner, J.; Heinzeb, R.; Humpage, A.R.; Mischke, U.; Eaglesha, G.K.; Chorus, I. Cylindrospermopsin occurrence in two German lakes and preliminary assessment of toxicity and toxin production of Cylindrospermopsis raciborskii (Cyanobacteria) isolates. Toxicon 2003, 42, 313–321. [Google Scholar]
  41. Bazin, E.; Huet, S.; Jarry, G.; Le He´garat, L.; Munday, J.S.; Humpage, A.R.; Fessard, V. Cytotoxic and genotoxic effects of cylindrospermopsin in mice treated by gavage or intraperitoneal injection. Environ. Toxicol. 2012, 27, 277–284. [Google Scholar]
  42. Stewart, I.; Schluter, P.J.; Shaw, G.R. Cyanobacterial lipopolysaccharides and human health—A review. Environ. Health 2006, 5, 7. [Google Scholar] [CrossRef]
  43. Teneva, I.; Mladenov, R.; Dzhambazov, B. Toxic effects of extracts from Pseudanabaena galeata (Cyanoprokaryota) in mice and cell cultures in vitro. Nat. Sci. Hum. 2009, 12, 237–243. [Google Scholar]
  44. Humpage, A.; Falconer, I.; Bernard, C.; Froscio, S.; Fabbro, L. Toxicity of the cyanobacterium Limnothrix AC0243 to male Balb/c mice. Water Res. 2012, 46, 1576–1583. [Google Scholar]
  45. Rangel, M.; Konno, K.; Brunaldi, K.; Procopio, J.; Freitas, J.C. Neurotoxic activity induced by a haemolytic substance in the extract of the marine sponge Geodia corticostylifera. Comp. Biochem. Physiol. (Part C) 2005, 141, 207–215. [Google Scholar]
  46. Grasso, A.; Alema, S.; Rufini, S.; Senni, M.I. Black widow spider toxin-induced calcium fluxes and transmitter release in neurosecretory cell line. Nature 1980, 283, 714–716. [Google Scholar]
  47. Robello, M.; Fresia, M.; Maga, L.; Grasso, A.; Ciani, S. Permeation of divalent cations through α-latrotoxin channels in lipid bilayers: steady-state current-voltage relationships. J. Membr. Biol. 1987, 95, 55–62. [Google Scholar]
  48. Lazarovici, P.; Primor, N.; Caratsch, C.G.; Munz, K.; Lelkes, P.; Loew, L.M.; Shai, Y.; Louini, K.; Contreras, M.L.; Fox, J.; et al. Action on Artificial and Neuronal Membranes of Pardaxin, a New Presynaptic Excitatory Polypeptide Neurotoxin with Ionophore Activity. In Neurotoxins in Neurochemistry, 1st ed.; Dolly, J.O., Ed.; Camelot: Southampton, UK, 1988; Volume 1, pp. 219–240. [Google Scholar]
  49. Shai, Y.; Fox, J.; Caratsch, C.; Shi, Y.L.; Edwards, C.; Lazarovici, P. Sequencing and synthesis of pardaxin, a polypeptide from the Red Sea Moses sole with ionophore activity. FEBS Lett. 1988, 242, 161–166. [Google Scholar]
  50. Shi, Y.L.; Edwards, C.; Lazarovici, P. Ion selectivity of the channels formed by pardaxin, an ionophore, in bilayer membranes. Nat. Toxins 1995, 3, 151–155. [Google Scholar]
  51. Berlinck, R.G.S.; Ogawa, C.A.; Almeida, A.M.P; Sanchez, M.A.A.; Malpezzi, E.L.A.; Costa, L.V.; Hajdu, E.; Freitas, J.C. Chemical and pharmacological characterization of halitoxin from Amphimedon viridis (Porifera) from the southeastern Brazilian coast. Comp. Biochem. Physiol. (Part C) 1996, 115, 155–163. [Google Scholar]
  52. Umbach, J.A.; Grasso, A.; Zurcher, S.D.; Kornblum, H.I.; Mastrogiacomo, A.; Gundersen, C.B. Electrical and optical monitoring of alatrotoxin action at Drosophila neuromuscular junctions. Neuroscience 1998, 87, 913–924. [Google Scholar]
  53. Yan, L.; Adams, M.E. Lycotoxins, antimicrobial peptides from venom of the wolf spider Lycosa carolinensis. J. Biol. Chem. 1998, 273, 2059–2066. [Google Scholar]
  54. Scott, R.H.; Whyment, A.D.; Gordon, K.H.; Milne, B.F.; Jaspars, M. Analysis of the structure and electrophysiological actions of halitoxins: 1,3 alkyl-pyridinium salts from Callyspongia ridleyi. J. Membr. Biol. 2000, 176, 119–131. [Google Scholar]
  55. Azevedo, M.T.P.; Sant’Anna, C.L. Sphaerocavum brasiliense, a new planktic genus and species of Cyanobacteria from reservoirs of Sao Paulo State, Brazil. Algol. Stud. 2003, 109, 79–92. [Google Scholar]
  56. Pyo, D.; Shin, H. Extraction and analysis of microcystins RR and LR in cyanobacteria using a cyano cartridge. J. Biochem. Biophys. Methods 2002, 51, 103–109. [Google Scholar]
  57. Rangel, M.; Cabrera, M.P.S.; Kazuma, K.; Ando, K.; Wang, X.; Kato, M.; Nihei, K.; Hirata, I.Y.; Cross, T.J.; Garcia, A.N.; et al. Chemical and biological characterization of four new linear cationic α-helical peptides from the venoms of two solitary eumenine wasps. Toxicon 2011, 57, 1081–1092. [Google Scholar]
  58. Rangel, M.; Malpezzi, E.L.A.; Susini, S.M.M.; Freitas, J.C. Hemolytic activity in extracts of the diatom Nitzschia. Toxicon 1997, 35, 305–309. [Google Scholar]

Share and Cite

MDPI and ACS Style

Rangel, M.; Martins, J.C.G.; Garcia, A.N.; Conserva, G.A.A.; Costa-Neves, A.; Sant'Anna, C.L.; De Carvalho, L.R. Analysis of the Toxicity and Histopathology Induced by the Oral Administration of Pseudanabaena galeata and Geitlerinema splendidum (Cyanobacteria) Extracts to Mice. Mar. Drugs 2014, 12, 508-524. https://doi.org/10.3390/md12010508

AMA Style

Rangel M, Martins JCG, Garcia AN, Conserva GAA, Costa-Neves A, Sant'Anna CL, De Carvalho LR. Analysis of the Toxicity and Histopathology Induced by the Oral Administration of Pseudanabaena galeata and Geitlerinema splendidum (Cyanobacteria) Extracts to Mice. Marine Drugs. 2014; 12(1):508-524. https://doi.org/10.3390/md12010508

Chicago/Turabian Style

Rangel, Marisa, Joyce C. G. Martins, Angélica Nunes Garcia, Geanne A. A. Conserva, Adriana Costa-Neves, Célia Leite Sant'Anna, and Luciana Retz De Carvalho. 2014. "Analysis of the Toxicity and Histopathology Induced by the Oral Administration of Pseudanabaena galeata and Geitlerinema splendidum (Cyanobacteria) Extracts to Mice" Marine Drugs 12, no. 1: 508-524. https://doi.org/10.3390/md12010508

Article Metrics

Back to TopTop